Original antigenic sin in dengue revisited

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 8761-8762

  Zompi, Simona ^a   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; DENGUE VACCINE; EPITOPE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE ANTIGEN;

ANTIGENICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS 1; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; INFECTION RISK; ISCHEMIA; NONHUMAN; NOTE; PRIORITY JOURNAL; SEROTYPING; T LYMPHOCYTE; VIRUS LOAD; VIRUS PATHOGENESIS;

CD8-POSITIVE T-LYMPHOCYTES; DENGUE; DENGUE VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY;

EID: 84878467903     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1306333110     Document Type: Note

References (22)

1. Bhatt S, et al. (2013) The global distribution and burden of dengue. Nature 496(7446):504-507.
2. Mongkolsapaya J, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9(7):921-927.
3. Rothman AL (2011) Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11(8):532-543.
4. Weiskopf D, et al. (2013) Comprehensive analysis of dengue virusspecific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci USA 110:E2046-E2053.
5. Yauch LE, et al. (2010) CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 185(9):5405-5416.
6. Yauch LE, et al. (2009) A protective role for dengue virus-specific CD8+ T cells. J Immunol 182(8):4865-4873.
7. Zompi S, Santich BH, Beatty PR, Harris E (2012) Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol 188(1):404-416.
8. Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62:71-92.
9. Gibbons RV, Vaughn DW (2002) Dengue: An escalating problem. BMJ 324(7353):1563-1566.
10. Shepard DS, Undurraga EA, Halasa YA (2013) Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis 7(2):e2055.
11. Halstead SB, Rojanasuphot S, Sangkawibha N (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32(1):154-156.
12. Halstead SB (1982) Immune enhancement of viral infection. Prog Allergy 31:301-364.
13. Sabchareon A, et al. (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet 380(9853):1559-1567.
14. Imrie A, et al. (2007) Antibody to dengue 1 detected more than 60 years after infection. Viral Immunol 20(4):672-675.
15. Simmons CP, et al. (2005) Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 79(9):5665-5675.
16. Livingston PG, Toomey S, Kurane I, Janus J, Ennis FA (1995) Modulation of the functions of dengue virus-specific human CD8+ cytotoxic T cell clone by IL-2, IL-7 and IFN gamma. Immunol Invest 24(4):619-629.
17. Gagnon SJ, Ennis FA, Rothman AL (1999) Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 73(5):3623-3629.
18. Mangada MM, Rothman AL (2005) Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175(4):2676-2683.
19. Green S, et al. (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179(4):755-762.
20. OhAinle M, et al. (2011) Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Science Transl Med 3(114): 114ra128.
21. Kanakaratne N, et al. (2009) Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 15(2):192-199.
22. Monteiro SP, et al. (2012) HLA-A*01 allele: A risk factor for dengue haemorrhagic fever in Brazil's population. Mem Inst Oswaldo Cruz 107(2):224-230.